Itali - Itali - AIFA (Agenzia Italiana del Farmaco)

bausch health ireland limited - teriflunomide - teriflunomide

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - asciminibum - compresse rivestite con film - asciminibum 20 mg ut asciminibi hydrochloridum 21.62 mg, lactosum monohydricum 43.11 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, carmellosum natricum conexum, poly(alcohol vinylicus), e 171, magnesii stearas, talcum, silica colloidalis anhydrica, lecithinum, e 172 (flavum), e 172 (rubrum), xanthani gummi, pro compresso obducto corresp. natrium max. 0.47 mg. - behandlung von erwachsenen patienten mit philadelphia-chromosom-positiver chronisch-myeloischer leukämie (ph+ cml) in der chronischen phase (cp) - synthetika

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - asciminibum - compresse rivestite con film - asciminibum 40 mg ut asciminibi hydrochloridum 43.24 mg, lactosum monohydricum 86.22 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, carmellosum natricum conexum, poly(alcohol vinylicus), e 171, magnesii stearas, talcum, silica colloidalis anhydrica, lecithinum, e 172 (rubrum), e 172 (nigrum), xanthani gummi, pro compresso obducto corresp. natrium max. 0.93 mg. - behandlung von erwachsenen patienten mit philadelphia-chromosom-positiver chronisch-myeloischer leukämie (ph+ cml) in der chronischen phase (cp) - synthetika

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - gemfibrozilum - compresse rivestite con film - gemfibrozilum 450 mg, cellulosum microcristallinum, amylum pregelificatum, silica colloidalis anhydrica, polysorbatum 80, carboxymethylamylum natricum a corresp. natrium 0.34 mg, magnesii stearas, Überzug: hypromellosum, simethiconum, talcum, macrogolum 6000, e 171, pro compresso obducto. - disturbi del metabolismo dei grassi - synthetika

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - gemfibrozilum - compresse rivestite con film - gemfibrozilum 900 mg, silica colloidalis anhydrica, silicii dioxidum praecipitatum, amylum pregelificatum, carboxymethylamylum natricum a corresp. natrium 0.68 mg, polysorbatum 80, magnesii stearas, Überzug: hypromellosum, simethiconum, talcum, macrogolum 6000, e 171, pro compresso obducto. - disturbi del metabolismo dei grassi - synthetika

Itali - Itali - AIFA (Agenzia Italiana del Farmaco)

organon italia s.r.l. - montelukast - montelukast

Itali - Itali - AIFA (Agenzia Italiana del Farmaco)

msd italia s.r.l. - montelukast - montelukast

Itali - Itali - AIFA (Agenzia Italiana del Farmaco)

neopharmed gentili s.p.a. - montelukast - montelukast

Itali - Itali - AIFA (Agenzia Italiana del Farmaco)

organon italia s.r.l. - montelukast - montelukast

Itali - Itali - AIFA (Agenzia Italiana del Farmaco)

siegfried gmbh - montelukast - montelukast